-
Topgen Biopharm Partners with Fudan University for Breast Cancer Gene Detection
•
Zhejiang-based tumor precision medicine specialist Topgen Biopharm Co., Ltd has entered into a strategic partnership with Fudan University Shanghai Cancer Center. The RMB 31 million (USD 4.5 million) deal will see the two Chinese entities collaborate on the translation of “breast cancer multi-gene detection” technology, marking a significant step forward…
-
Roche Diagnostics and Topgen Biopharm Launch Innovation Center in Chongqing
•
Swiss diagnostics giant Roche Diagnostics and China-based Topgen Biopharm announced the establishment of a strategic partnership on July 24, with the inauguration of the “Roche Diagnostics-Topgen Innovation Center of Excellence” in Chongqing. Center OverviewThe innovation center comprises several key facilities:
